Observational Study to Evaluate the Safety & Efficacy of ATG-F on Kidney

See also
Status	Clinical Trial	Phase
Completed	`NCT01336296` - Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients	Phase 4
Recruiting	`NCT01150487` - Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients	N/A
Recruiting	`NCT05938712` - The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients	Phase 2
Completed	`NCT00217100` - A Multivitamin Comparison Study in Kidney Transplant Recipients.	Phase 3
Active, not recruiting	`NCT00199667` - Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients	Phase 4
Terminated	`NCT01517984` - Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation	Phase 2
Recruiting	`NCT04642833` - Prostate Cancer in Renal Transplants Recipients
Not yet recruiting	`NCT05293704` - An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients	Phase 4
Completed	`NCT02555566` - Role of Epoxyeicosatrienoic Acids in Chronic Allograft Nephropathy - The TRANSPLANT-EETs Study	N/A
Completed	`NCT01782586` - Validation of Gene Expression Markers of Renal Allograft Functional Decline
Enrolling by invitation	`NCT02042963` - KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT)	N/A
Not yet recruiting	`NCT05702398` - Pilot Trial of Supplemental Vitamin A and Nicotinamide	Early Phase 1
Active, not recruiting	`NCT05425498` - The Effects of Physical Activity Behavior Change in Kidney Transplant Recipients	N/A
Completed	`NCT01889758` - Pharmacokinetic Studies of Tacrolimus in Transplant Patients	Phase 4
Terminated	`NCT02268201` - A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule	Phase 4
Active, not recruiting	`NCT03979365` - Envarsus XR Compared to Immediate Release Tacrolimus	Phase 4
Recruiting	`NCT04965935` - Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients	Phase 3
Recruiting	`NCT04444843` - Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen	Phase 4
Completed	`NCT02639949` - Measuring and Improving Medication Adherence in Kidney Transplant Patients	N/A
Withdrawn	`NCT02058875` - Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring	Phase 4

NCT number	NCT02392312
Study type	Observational
Source	Astellas Pharma Inc
Contact
Status	Completed
Phase
Start date	January 21, 2015
Completion date	March 16, 2018

Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms